$ETRM,
Analysts Advise About EnteroMedics Inc. (NASDAQ:ETRM)
By
Francis Lewis -
November 23, 2016
EnteroMedics Inc. (NASDAQ:ETRM) stock is presently standing at about $0.09 and lots of equity research firms seem to have a target price set on the stock. The median one-year price target of 2 analysts covering the company is $1.10, which suggests the stock could still rise over 92 percent. The highest analyst price target is $2.00, which implies a rally of -2022 percent. And a quick view of analyst notes show that 1 are rating the stock a buy while 0 rate ETRM a strong buy. There are 1 equity research firms advocating a Hold and 0 consider it Sell.
ROTH Capital analysts provided their view on EnteroMedics Inc. (NASDAQ:ETRM) recently. The rating firm issued a Neutral rating to this company in a research note released on Jun 09, 2016. Northland Securities analysts disclosed their opinion on EnteroMedics Inc. (NASDAQ:ETRM) recently. The rating firm gave a Outperform rating to this stock in a research note published on Jun 29, 2012. According to a research note disclosed on Jan 09, 2009, analysts at Argus have lowered their rating on these shares from Hold to Sell.
EnteroMedics Inc. (NASDAQ:ETRM) Transactions Roundup
Several insiders were part of recent insider activity for the stock. Its SVP, Ops & Bus Dev DeLange Peter M. Purchased 20,000 company shares for $11000, in a transaction on 2016-06-03. Following the transaction, the SVP, Ops & Bus Dev is left with a stake of 11 shares, currently valued at $1. Meanwhile, CEO GLADNEY DAN W purchased 50,000 shares worth $135000, through a transaction dated 2015-11-12. Following the completion of the transaction, the insider is left with a stake of 50,000 shares, amounting $4500. ETRM Chrmn, Pres & CEO KNUDSON MARK B also purchased 20,667 shares, at a stock price of $2.4. This transaction occurred on 2015-11-12 totals $49000.6. After this transaction, the insider’s stake stands at 45,011 shares, with a market value of $4051.
Executives hold 0.99 percent of the stock. Kevin G. Douglas is one of the biggest insider owners in EnteroMedics Inc. (NASDAQ:ETRM), according to U.S. Securities and Exchange Commission (SEC) filings. The insider owns 3,010,852 shares which have current market value of around $270976.68.Mr. Dan W. Gladney is another major inside shareholder in the company. The insider owns 134,745 shares as of 0.12%, currently worth $12127.05. Dr. Mark B. Knudson, PhD is ranked as third insider holder of the stock. This insider holds 40,867 shares with a market value around $3678.03 as of recent close.
EnteroMedics Inc. (NASDAQ:ETRM) Earnings Outlook
In EnteroMedics Inc. (NASDAQ:ETRM)’s latest quarter, EPS moved to $-0.17 from $-0.49 in preceding quarter and revenues reached at $0.30M compared to $0.28M. Analysts had expected EnteroMedics Inc. (NASDAQ:ETRM) to post net income of about $-0.50 per share on $0.34M in revenue. Looking ahead, analysts on average predict that earnings for the current quarter would come in in the range of $-0.50 to $-0.38. That is compared with the $-0.95 in EPS it reported during the same period a year ago.
Analysts Advise About EnteroMedics Inc. (NASDAQ:ETRM)
By
Francis Lewis -
November 23, 2016
EnteroMedics Inc. (NASDAQ:ETRM) stock is presently standing at about $0.09 and lots of equity research firms seem to have a target price set on the stock. The median one-year price target of 2 analysts covering the company is $1.10, which suggests the stock could still rise over 92 percent. The highest analyst price target is $2.00, which implies a rally of -2022 percent. And a quick view of analyst notes show that 1 are rating the stock a buy while 0 rate ETRM a strong buy. There are 1 equity research firms advocating a Hold and 0 consider it Sell.
ROTH Capital analysts provided their view on EnteroMedics Inc. (NASDAQ:ETRM) recently. The rating firm issued a Neutral rating to this company in a research note released on Jun 09, 2016. Northland Securities analysts disclosed their opinion on EnteroMedics Inc. (NASDAQ:ETRM) recently. The rating firm gave a Outperform rating to this stock in a research note published on Jun 29, 2012. According to a research note disclosed on Jan 09, 2009, analysts at Argus have lowered their rating on these shares from Hold to Sell.
EnteroMedics Inc. (NASDAQ:ETRM) Transactions Roundup
Several insiders were part of recent insider activity for the stock. Its SVP, Ops & Bus Dev DeLange Peter M. Purchased 20,000 company shares for $11000, in a transaction on 2016-06-03. Following the transaction, the SVP, Ops & Bus Dev is left with a stake of 11 shares, currently valued at $1. Meanwhile, CEO GLADNEY DAN W purchased 50,000 shares worth $135000, through a transaction dated 2015-11-12. Following the completion of the transaction, the insider is left with a stake of 50,000 shares, amounting $4500. ETRM Chrmn, Pres & CEO KNUDSON MARK B also purchased 20,667 shares, at a stock price of $2.4. This transaction occurred on 2015-11-12 totals $49000.6. After this transaction, the insider’s stake stands at 45,011 shares, with a market value of $4051.
Executives hold 0.99 percent of the stock. Kevin G. Douglas is one of the biggest insider owners in EnteroMedics Inc. (NASDAQ:ETRM), according to U.S. Securities and Exchange Commission (SEC) filings. The insider owns 3,010,852 shares which have current market value of around $270976.68.Mr. Dan W. Gladney is another major inside shareholder in the company. The insider owns 134,745 shares as of 0.12%, currently worth $12127.05. Dr. Mark B. Knudson, PhD is ranked as third insider holder of the stock. This insider holds 40,867 shares with a market value around $3678.03 as of recent close.
EnteroMedics Inc. (NASDAQ:ETRM) Earnings Outlook
In EnteroMedics Inc. (NASDAQ:ETRM)’s latest quarter, EPS moved to $-0.17 from $-0.49 in preceding quarter and revenues reached at $0.30M compared to $0.28M. Analysts had expected EnteroMedics Inc. (NASDAQ:ETRM) to post net income of about $-0.50 per share on $0.34M in revenue. Looking ahead, analysts on average predict that earnings for the current quarter would come in in the range of $-0.50 to $-0.38. That is compared with the $-0.95 in EPS it reported during the same period a year ago.
1
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
